Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07311057
Eligibility Criteria:
Inclusion Criteria:
* Histopathologically confirmed diagnosis of squamous cell carcinoma (SCC)
* Provision of written informed consent to participate in the study
* Lack of willingness or eligibility for surgical excision or radiotherapy, or contraindication to intralesional medical treatments such as interferon-alpha or 5-fluorouracil (5-FU)
* Age ≥ 18 years
* Lesion size \< 2 cm in diameter
* Presence of multiple lesions
Exclusion Criteria:
* Withdrawal of consent at any stage of the study
* Pregnancy or breastfeeding
* History of severe adverse reactions to medications
* Inability or unwillingness to attend follow-up visits
* History of cardiovascular disease
* History of thromboembolic disorders
* Prior radiotherapy to the affected area
* History of chronic arsenic exposure
* Immunodeficiency
* Presence of severe systemic illness
* Known allergy or hypersensitivity to methylene blue
* History of bleeding disorders or abnormal coagulation
* Severe inflammatory or dermatologic conditions in the treatment area
* Failure to complete the full course of treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07311057
Study Brief:
Protocol Section:
NCT07311057